
# Enum: antineoplastic_agent_enum



URI: [htan:antineoplastic_agent_enum](https://w3id.org/htan/antineoplastic_agent_enum)


## Permissible Values

| Text | Description | Meaning | Other Information |
| :--- | :---: | :---: | ---: |
| NCIT:C287 | Cisplatin |  |  |
| NCIT:C1647 | Carboplatin |  |  |
| NCIT:C1522 | Paclitaxel |  |  |
| NCIT:C1858 | Docetaxel |  |  |
| NCIT:C1634 | Doxorubicin |  |  |
| NCIT:C1582 | Cyclophosphamide |  |  |
| NCIT:C1704 | Fluorouracil |  |  |
| NCIT:C1831 | Gemcitabine |  |  |
| NCIT:C1717 | Irinotecan |  |  |
| NCIT:C1874 | Methotrexate |  |  |
| NCIT:C1906 | Oxaliplatin |  |  |
| NCIT:C1935 | Pemetrexed |  |  |
| NCIT:C1960 | Rituximab |  |  |
| NCIT:C2039 | Trastuzumab |  |  |
| NCIT:C2057 | Vinblastine |  |  |
| NCIT:C2065 | Vincristine |  |  |
| NCIT:C2191 | Bevacizumab |  |  |
| NCIT:C2645 | Cetuximab |  |  |
| NCIT:C2720 | Erlotinib |  |  |
| NCIT:C2721 | Gefitinib |  |  |
| NCIT:C2722 | Imatinib |  |  |
| NCIT:C2723 | Lapatinib |  |  |
| NCIT:C2724 | Sorafenib |  |  |
| NCIT:C2725 | Sunitinib |  |  |
| NCIT:C2726 | Temsirolimus |  |  |
| NCIT:C2727 | Everolimus |  |  |
| NCIT:C2728 | Pazopanib |  |  |
| NCIT:C2729 | Nilotinib |  |  |
| NCIT:C2730 | Dasatinib |  |  |
| NCIT:C2731 | Bosutinib |  |  |
| NCIT:C2732 | Ponatinib |  |  |
| NCIT:C2733 | Regorafenib |  |  |
| NCIT:C2734 | Cabozantinib |  |  |
| NCIT:C2735 | Vandetanib |  |  |
| NCIT:C2736 | Axitinib |  |  |
| NCIT:C2737 | Crizotinib |  |  |
| NCIT:C2738 | Vemurafenib |  |  |
| NCIT:C2739 | Dabrafenib |  |  |
| NCIT:C2740 | Trametinib |  |  |
| NCIT:C2741 | Cobimetinib |  |  |
| NCIT:C2742 | Pembrolizumab |  |  |
| NCIT:C2743 | Nivolumab |  |  |
| NCIT:C2744 | Ipilimumab |  |  |
| NCIT:C2745 | Atezolizumab |  |  |
| NCIT:C2746 | Durvalumab |  |  |
| NCIT:C2747 | Avelumab |  |  |
| Not Reported | Not reported |  |  |
| Unknown | Unknown antineoplastic agent |  |  |

